GPC3 and hepatoblastoma: To exclude Wnt signaling, we chose HepG2, a GPC3-positive hepatoblastoma cell line expressing a constitutively activated β-catenin [32], to establish a xenograft model and evaluate the anti-tumor activity of the HS20 antibody.